4//SEC Filing
Palmedo Philip F 4
Accession 0001493152-22-021183
CIK 0001335105other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:46 PM ET
Size
14.1 KB
Accession
0001493152-22-021183
Insider Transaction Report
Form 4
Palmedo Philip F
Director
Transactions
- Award
Options to Purchase Common Stock
2022-06-30+100,000→ 100,000 totalExercise: $0.74From: 2022-06-30Exp: 2027-06-30→ Common (100,000 underlying)
Holdings
- 16,667(indirect: By Philip Palmedo L.P..)
Warrants to Purchase Common Stock
Exercise: $6.00From: 2018-12-07Exp: 2022-12-07→ Common (16,667 underlying) - 8,333
Options to Purchase Common Stock
Exercise: $6.60From: 2019-05-22Exp: 2024-05-22→ Common (8,333 underlying) - 75,000
Options to Purchase Common Stock
Exercise: $0.72From: 2016-04-25Exp: 2021-04-25→ Common (75,000 underlying) - 8,333
Options to Purchase Common Stock
Exercise: $0.90From: 2017-10-16Exp: 2022-10-16→ Common (8,333 underlying) - 100,000
Options to Purchase Common Stock
Exercise: $3.03From: 2021-06-30Exp: 2026-06-30→ Common (100,000 underlying) - 50,000
Options to Purchase Common Stock
Exercise: $3.21From: 2021-01-06Exp: 2026-01-06→ Common (50,000 underlying) - 21,053
Warrants to Purchase Common Stock
Exercise: $5.70From: 2020-11-30Exp: 2025-11-30→ Common (21,053 underlying)
Footnotes (1)
- [F1]Effective June 30, 2022, the reporting person was granted stock options to purchase an aggregate of 100,000 shares, vesting on the last day of each subsequent quarter until fully vested (e.g. vesting to start on September 30, 2022).
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0001369455
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 4:46 PM ET
- Size
- 14.1 KB